ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

2 links2 made here, not in the record2 judgments1 judge (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Made here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07633353Real-World Outcomes ofFirst-Line Treatment ofMetastatic or LocallyAdvanced Upper TractUrothelial Carcinoma WithEnfortumab Vedotin PlusPembrolizumab : A FrenchCentre Hospitalier Universitaienrolling by invitationRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.DRUGSPembrolizumabMade here · Found by reading; no entr…›Nov 1 · Claude Opus 5.5 · ExposureExposureEnfortumab vedotinMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Pembrolizumab

Made here1 judgment on this link
NCT07633353gives it, found by reading the recordPembrolizumabDefined by Claude Opus 5.5Nov 1, 2026, 9:53 AM UTC
Role in the study, from the registry to what was judged
RegistryNot in the recordno intervention entry names it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1Pembrolizumabmade hereClaude Opus 5.5ExposureCurrent
Nov 10Enfortumab vedotinmade hereClaude Opus 5.5ExposureCurrent